Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States

por Bungey, George, Chang-Douglass, Stacey, Hsu, Ming-Ann, Cappelleri, Joseph C., Young, Pamela, Woolcott, John
Publicado 2020

Immediate birth for women between 34 and 37 weeks of gestation with prolonged preterm prelabour rupture of membranes and detection of vaginal or urine group B streptococcus: an eco...

por Dietz, Jeremy, Plumb, Jane, Banfield, Philip, Soe, Aung, Chehadah, Fadi, Chang‐Douglass, Stacey, Rogers, Gabriel
Publicado 2022

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

por Gladman, Dafna D., Orbai, Ana-Maria, Gomez-Reino, Juan, Chang-Douglass, Stacey, Leoncini, Emanuele, Burton, Hannah E., Kanik, Keith S., Romero, Ana Belen, Cappelleri, Joseph C., Hsu, Ming-Ann
Publicado 2020